Alterity Therapeutics (ATHE) Shares Outstanding (Weighted Average) (2017 - 2018)

Alterity Therapeutics (ATHE) has 2 years of Shares Outstanding (Weighted Average) data on record, last reported at $404.2 million in Q2 2018.

  • For Q2 2018, Shares Outstanding (Weighted Average) rose 0.78% year-over-year to $404.2 million; the TTM value through Jun 2018 reached $404.2 million, up 0.78%, while the annual FY2018 figure was $404.2 million, 0.39% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $404.2 million in Q2 2018 per ATHE's latest filing, up from $401.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $404.2 million in Q2 2018 and bottomed at $401.1 million in Q2 2017.